HELLUMS RHONDA LYNETTE bought SLN
January 2, 2026 · Form 4 insider transaction
HELLUMS RHONDA LYNETTE bought 375,000 shares of Silence Therapeutics plc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
375,000
Price
$0.00
Total value
N/A
InsiderHELLUMS RHONDA LYNETTE
RoleOfficer, Director
SecurityEmployee Share Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2026
Filing dateJanuary 6, 2026
Shares owned after375,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
One fourth (1/4th) of the shares subject to the option shall vest on January 2, 2027 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each such vesting date.